Novo Nordisk stock tumbles 15% despite strong earnings: here’s what spooked investors
Novo Nordisk stock (NVO) plunged approximately 15% after the Danish pharmaceutical giant posted better-than-expected 2025 results but delivered a weak 2026 outlook.The









